Although its interaction partners did not show enrichment in any T2D related pathway, previous literature had reported that Sell was associated with T2D-associated pathologies, such as diabetic microangiopathy [54], nephropathy [55] and diabetic retinopathy [56]. This evidence concerns the gene SELL and diabetic retinopathy.